Stockreport

Eccogene Announces Positive Phase 1 Data for Oral THR-ß Full Agonist and Oral SSAO Inhibitor in Late-Breaking Poster Presentations at the American Association for the Study of Liver Diseas...

Thermo Fisher Scientific Inc  (TMO) 
Last thermo fisher scientific inc earnings: 4/22 06:00 am Check Earnings Report
PDF BOSTON and SHANGHAI, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics [Read more]